New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Prenetics Global Limited
PRE
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

52M

Medical - Diagnostics & Research

Next Earning date - 18 Nov 2024

52M

Medical - Diagnostics & Research

Next Earning date - 18 Nov 2024

4.29USD
Shape0.11 ( 2.63%)
favorite-chart

Relative Strenght

31
favorite-chart

Volume Buzz

-50%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

45%

Quote Panel

Shape
Updated October 12, 2024
1W -6.74 % 1M -4.67 % 3M -30.47 % 1Y -33.49 %

Key Metrics

Shape
  • Market Cap

    52.41M


  • Shares Outstanding

    12.22M


  • Share in Float

    9.48M


  • Dividende

    0


  • Earning Date

    18 Nov 2024


  • Price Target

    4.29


  • Average Volume

    18432


  • Beta

    -0.166


  • Range

    2.85-7.838


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.prenetics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.31x

P/S Ratio

0.28x

P/B Ratio

0.0

Debt/Equity

-229.2%

Net Margin

$-3.5

EPS

How PRE compares to sector?

P/E Ratio

Relative Strength

Shape

PRE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$90M

Shape1415%

2025-Revenue

$0.56

Shape36%

2025-EPS

$44M

Shape-362%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+141%

4.5
vs -10.87

Q4.22

arrow
arrow

+120%

0.9
vs -4.46

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

-0.15
vs 0.6

Q3.23

arrow
arrow

N/A

-0.04
vs 4.5

Q4.23

arrow
arrow

N/A

NA
vs 0.9

Q1.24

arrow
arrow

N/A

-0.52
vs NA

Q2.24

arrow
arrow

N/A

NA
vs -0.15

Q3.24

arrow
arrow

N/A

-0.86
vs -0.04

Q4.24

arrow
arrow

N/A

-0.77
vs NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+7%

79.7M  vs 74.7M

Q4.22

arrow
arrow

-19%

52.3M  vs 64.7M

Q1.23

arrow
arrow

-81%

17.7M  vs 92M

Q2.23

arrow
arrow

-89%

5.7M  vs 51.7M

Q3.23

arrow
arrow

-94%

4.9M  vs 79.7M

Q4.23

arrow
arrow

-90%

5.4M  vs 52.3M

Q1.24

arrow
arrow

-64%

6.4M  vs 17.7M

Q2.24

arrow
arrow

+4%

5.9M  vs 5.7M

Q3.24

arrow
arrow

+89%

9.2M  vs 4.9M

Q4.24

arrow
arrow

+123%

12.1M  vs 5.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-7%

-0.07
vs -0.66

Q4.22

arrow
arrow

+1%

0.01
vs -0.07

Q1.23

arrow
arrow

-5%

-0.05
vs 0.01

Q2.23

arrow
arrow

-10%

-0.10
vs -0.05

Q3.23

arrow
arrow

-6%

-0.06
vs -0.10

Q4.23

arrow
arrow

-9%

-0.09
vs -0.06

Q1.24

arrow
arrow

-4%

-0.04
vs -0.09

Q2.24

arrow
arrow

-6%

-0.06
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

12

12
vs NA

NA

Q3.22

arrow
arrow

10

10
vs 12

-17%

Q4.22

arrow
arrow

13

13
vs 10

30%

Q1.23

arrow
arrow

15

15
vs 13

15%

Q2.23

arrow
arrow

21

21
vs 15

40%

Q3.23

arrow
arrow

16

16
vs 21

-24%

Q4.23

arrow
arrow

1

1
vs 16

-94%

Q1.24

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News